Evidence map›Paper›PMID 29941991›Full record

Trial reportScientific reports2018

Phytate Decreases Formation of Advanced Glycation End-Products in Patients with Type II Diabetes: Randomized Crossover Trial.

Pilar Sanchis, Rosmeri Rivera, Francisco Berga, Regina Fortuny, Miquel Adrover, Antonia Costa-Bauza, Felix Grases, Luis Masmiquel

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
6.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 64 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. An Angiotensin II Receptor Blocker Suppresses Glucose-Induced Oxidative Stress in Human Rotator Cuff-Derived Cells.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Pilar SanchisEndocrinology Department, Research Unit, Hospital Son Llàtzer, Institute of Health Sciences Research [IUNICS- IdISBa], 07198, Palma of Mallorca, Spain. psanchis@ssib.es.
Rosmeri RiveraEndocrinology Department, Research Unit, Hospital Son Llàtzer, Institute of Health Sciences Research [IUNICS- IdISBa], 07198, Palma of Mallorca, Spain.
Francisco BergaLaboratory of Renal Lithiasis Research, University of Balearic Islands, Institute of Health Sciences Research [IUNICS- IdISBa], 07122, Palma of Mallorca, Spain.
Regina FortunyLaboratory Department, Hospital Son Llàtzer, 07198, Palma of Mallorca, Spain.
Miquel AdroverDepartment of Chemistry, University of Balearic Islands, Ctra. Valldemossa km 7.5, 07122, Palma of Mallorca, Spain.
Antonia Costa-BauzaLaboratory of Renal Lithiasis Research, University of Balearic Islands, Institute of Health Sciences Research [IUNICS- IdISBa], 07122, Palma of Mallorca, Spain.
Felix GrasesLaboratory of Renal Lithiasis Research, University of Balearic Islands, Institute of Health Sciences Research [IUNICS- IdISBa], 07122, Palma of Mallorca, Spain.
Luis MasmiquelEndocrinology Department, Research Unit, Hospital Son Llàtzer, Institute of Health Sciences Research [IUNICS- IdISBa], 07198, Palma of Mallorca, Spain. lmasmiquel@hsll.es.
Health Research Institute of the Balearic Islands · ESHospital Son Llatzer · ESResearch Institute of Health Sciences · ESUniversitat de les Illes Balears · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myo-inositol hexaphosphate (phytate; IP6) is a natural compound that is abundant in cereals, legumes, and nuts and it has the ability to chelate metal cations. The binding of IP6 to transition metals suggests that it could be used for the treatment of metal-catalyzed protein glycation, which appears to trigger diabetes-related diseases. Our in vitro studies showed that IP6 reduced the formation of Fe

Indexed as

AgedBlood GlucoseCross-Over StudiesDiabetes Mellitus, Type 2FemaleGlycated HemoglobinGlycation End Products, AdvancedHumansMaleMiddle AgedPhytic AcidSafetyBlood GlucoseGlycated HemoglobinGlycation End Products, Advancedhemoglobin A1c protein, humanPhytic Acid

Identifiers

PMID29941991
PMCPMC6018557
OpenAlexW2808910769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.